StockScouter

The StockScouter® System is a proprietary stock scoring model which covers U.S. companies listed on the major exchanges. The 10 (best) to 1 (worst) score is derived from Fundamental, Technical, Ownership, and Valuation sub-models in combination with a Risk model which assesses the expected risk and return.

StockScouter Screening Tool StockScouter Top 50

ITCI INTRA CELLULAR THERAPIES INCORPORATED StockScouter® Report

4

StockScouter® Score

INTRA CELLULAR THERAPIES INCORPORATED, a small cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • An executive, director or major shareholder purchased a large number of shares recently. Postive/Neutral

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 80% done.
Progress: 40% done.
Low
High

Core Model Grades

B
A
N/A
F

Previous Ratings

4
4
5